[{"address1": "1560 Trapelo Road", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 786 8230", "fax": "781 786 8866", "website": "https://www.dyne-tx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 191, "companyOfficers": [{"maxAge": 1, "name": "Mr. John G. Cox M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 1028185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Oxana  Beskrovnaya Ph.D.", "age": 63, "title": "Chief Innovation Officer", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 719521, "exercisedValue": 2172731, "unexercisedValue": 3736735}, {"maxAge": 1, "name": "Ms. Johanna  Friedl-Naderer", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 748769, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Douglas  Kerr M.B.A., M.D., Ph.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 745640, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Erick J. Lucera C.F.A., CPA", "age": 56, "title": "CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rajesh  Manchanda Ph.D.", "age": 58, "title": "Chief Technical Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James P. Bilotta M.B.A.", "title": "Chief Digital & Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ranjan  Batra Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Wilson", "age": 52, "title": "Senior VP & Head of Legal", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lucia  Celona", "age": 58, "title": "Chief Human Resource Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 18.205, "open": 17.81, "dayLow": 17.025, "dayHigh": 18.39, "regularMarketPreviousClose": 18.205, "regularMarketOpen": 17.81, "regularMarketDayLow": 17.025, "regularMarketDayHigh": 18.39, "payoutRatio": 0.0, "forwardPE": -5.810127, "volume": 3611774, "regularMarketVolume": 3611774, "averageVolume": 2645839, "averageVolume10days": 4023780, "averageDailyVolume10Day": 4023780, "bid": 12.99, "ask": 21.99, "bidSize": 2, "askSize": 2, "marketCap": 2622261248, "fiftyTwoWeekLow": 6.36, "fiftyTwoWeekHigh": 35.68, "allTimeHigh": 47.45, "allTimeLow": 4.3, "fiftyDayAverage": 15.5598, "twoHundredDayAverage": 12.516975, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1950840192, "profitMargins": 0.0, "floatShares": 123106311, "sharesOutstanding": 142824687, "sharesShort": 17097410, "sharesShortPriorMonth": 15303535, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.12020001, "heldPercentInsiders": 0.00495, "heldPercentInstitutions": 0.95228, "shortRatio": 6.73, "shortPercentOfFloat": 0.1342, "impliedSharesOutstanding": 142824687, "bookValue": 4.851, "priceToBook": 3.784787, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -423800992, "trailingEps": -3.62, "forwardEps": -3.16, "enterpriseToEbitda": -4.362, "52WeekChange": -0.35282618, "SandP52WeekChange": 0.1198014, "quoteType": "EQUITY", "currentPrice": 18.36, "targetHighPrice": 50.0, "targetLowPrice": 12.0, "targetMeanPrice": 35.41176, "targetMedianPrice": 36.0, "recommendationMean": 1.64706, "recommendationKey": "buy", "numberOfAnalystOpinions": 17, "totalCash": 791886976, "totalCashPerShare": 5.544, "ebitda": -447184992, "totalDebt": 120466000, "quickRatio": 13.231, "currentRatio": 13.472, "debtToEquity": 17.414, "returnOnAssets": -0.34320998, "returnOnEquity": -0.60659003, "freeCashflow": -241355632, "operatingCashflow": -375710016, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "DYN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1762561213, "regularMarketTime": 1762549201, "exchange": "NMS", "messageBoardId": "finmb_608699906", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.851418, "regularMarketPrice": 18.36, "shortName": "Dyne Therapeutics, Inc.", "longName": "Dyne Therapeutics, Inc.", "marketState": "CLOSED", "epsTrailingTwelveMonths": -3.62, "epsForward": -3.16, "epsCurrentYear": -3.62915, "priceEpsCurrentYear": -5.0590363, "fiftyDayAverageChange": 2.8002005, "fiftyDayAverageChangePercent": 0.17996378, "twoHundredDayAverageChange": 5.843025, "twoHundredDayAverageChangePercent": 0.46680808, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-17", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1600349400000, "postMarketChangePercent": 1.9607772, "postMarketPrice": 18.72, "postMarketChange": 0.3599987, "regularMarketChange": 0.155001, "regularMarketDayRange": "17.025 - 18.39", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2645839, "fiftyTwoWeekLowChange": 12.0, "fiftyTwoWeekLowChangePercent": 1.8867924, "fiftyTwoWeekRange": "6.36 - 35.68", "fiftyTwoWeekHighChange": -17.32, "fiftyTwoWeekHighChangePercent": -0.485426, "fiftyTwoWeekChangePercent": -35.28262, "earningsTimestampStart": 1762549200, "earningsTimestampEnd": 1762549200, "isEarningsDateEstimate": true, "displayName": "Dyne Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]